Standout Papers

Diagnosis and Management of the Metabolic Syndrome 1995 2026 2005 2015 9.2k
  1. Diagnosis and Management of the Metabolic Syndrome (2005)
    Scott M. Grundy, James I. Cleeman et al. Circulation
  2. Diagnosis and Management of the Metabolic Syndrome (2005)
    Scott M. Grundy, James I. Cleeman et al. Cardiology in Review
  3. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update (2011)
    Sidney C. Smith, Emelia J. Benjamin et al. Circulation
  4. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure (2000)
    Charles Porter, Dennis R. Bresnahan et al. Journal of the American College of Cardiology
  5. Development and evaluation of the Seattle Angina questionnaire: A new functional status measure for coronary artery disease (1995)
    John A. Spertus, Timothy A. Dewhurst et al. Journal of the American College of Cardiology
  6. Telemonitoring in Patients with Heart Failure (2010)
    Sarwat I. Chaudhry, Jennifer A. Mattera et al. New England Journal of Medicine
  7. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project) (2017)
    Jiapeng Lu, Yuan Lu et al. The Lancet
  8. Medical Therapy for Heart Failure With Reduced Ejection Fraction (2018)
    Stephen J. Greene, Javed Butler et al. Journal of the American College of Cardiology
  9. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update (2011)
    Sidney C. Smith, Emelia J. Benjamin et al. Journal of the American College of Cardiology
  10. Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement (2006)
    John A. Spertus, Carole Decker et al. Circulation
  11. Diagnosis and Management of the Metabolic Syndrome (2005)
    Scott M. Grundy, James I. Cleeman et al. Circulation
  12. Decision Making in Advanced Heart Failure (2012)
    Larry A. Allen, Lynne W. Stevenson et al. Circulation
  13. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention (2016)
    Robert W. Yeh, Eric A. Secemsky et al. JAMA
  14. Effects of Exercise Training on Health Status in Patients With Chronic Heart Failure (2009)
    Kathryn E. Flynn, Ileana L. Piña et al. JAMA
  15. Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document (2018)
    Héctor M. García‐García, Eugène McFadden et al. Circulation
  16. Contemporary Incidence, Predictors, and Outcomes of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions (2014)
    Thomas T. Tsai, Uptal D. Patel et al. JACC: Cardiovascular Interventions
  17. Cardiovascular Health: The Importance of Measuring Patient-Reported Health Status (2013)
    John S. Rumsfeld, Karen P. Alexander et al. Circulation
  18. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update (2012)
    Manesh R. Patel, Gregory Dehmer et al. Journal of the American College of Cardiology
  19. Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden (2015)
    Jason R. Stubbs, John A. House et al. Journal of the American Society of Nephrology
  20. Trends in Acute Myocardial Infarction in Young Patients and Differences by Sex and Race, 2001 to 2010 (2014)
    Aakriti Gupta, Yongfei Wang et al. Journal of the American College of Cardiology
  21. The National Cardiovascular Data Registry (NCDR) Data Quality Brief (2012)
    John C. Messenger, Kalon K.L. Ho et al. Journal of the American College of Cardiology
  22. Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire (2015)
    John A. Spertus, Philip G. Jones Circulation Cardiovascular Quality and Outcomes
  23. Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction (2019)
    Stephen J. Greene, Gregg C. Fonarow et al. Journal of the American College of Cardiology
  24. Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care (2020)
    John A. Spertus, Philip G. Jones et al. Journal of the American College of Cardiology
  25. Presentation, Clinical Profile, and Prognosis of Young Patients With Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): Results From the VIRGO Study (2018)
    Basmah Safdar, Erica S. Spatz et al. Journal of the American Heart Association
  26. The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support (2019)
    Amit P. Amin, John A. Spertus et al. Circulation
  27. ST-segment elevation myocardial infarction (2019)
    Birgit Vogel, Bimmer E. Claessen et al. Nature Reviews Disease Primers
  28. The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial (2022)
    John A. Spertus, Mary C. Birmingham et al. Nature Medicine
  29. Use of Machine Learning Models to Predict Death After Acute Myocardial Infarction (2021)
    Rohan Khera, Julian S. Haimovich et al. JAMA Cardiology
  30. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial (2021)
    John A. Spertus, Jennifer Fine et al. The Lancet
  31. Racial and Ethnic Differences in Bystander CPR for Witnessed Cardiac Arrest (2022)
    John A. Spertus, Saket Girotra et al. New England Journal of Medicine

Immediate Impact

3 from Science/Nature 86 standout
Sub-graph 1 of 20

Citing Papers

Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
2024 Standout
Wearable Digital Health Technologies for Monitoring in Cardiovascular Medicine
2024 Standout
5 intermediate papers

Works of John A. Spertus being referenced

Medical Therapy for Heart Failure With Reduced Ejection Fraction
2018 Standout
Telemonitoring in Patients with Heart Failure
2010 Standout
and 15 more

Author Peers

Author Last Decade Papers Cites
John A. Spertus 39342 14490 8740 1.1k 64.8k
Donald M. Lloyd‐Jones 33587 17512 6181 716 66.3k
Eric D. Peterson 45772 20943 7784 1.2k 77.4k
Gregg C. Fonarow 76391 17156 6508 1.8k 109.2k
Sidney C. Smith 26549 19248 6498 306 65.7k
Josef Coresh 29995 15647 5682 936 112.1k
Roger S. Blumenthal 19874 11826 10400 745 43.0k
Martin G. Larson 51911 12342 6429 580 86.7k
Emelia J. Benjamin 68687 11568 9327 766 98.8k
Philip Greenland 19627 12931 8415 446 43.6k
Gregory L. Burke 21094 7972 7773 344 55.8k

All Works

Loading papers...

Rankless by CCL
2026